207 related articles for article (PubMed ID: 28534645)
41. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
[TBL] [Abstract][Full Text] [Related]
42. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
de Koning MLY; Westenbrink BD; Assa S; Garcia E; Connelly MA; van Veldhuisen DJ; Dullaart RPF; Lipsic E; van der Harst P
J Am Coll Cardiol; 2021 Oct; 78(14):1421-1432. PubMed ID: 34593124
[TBL] [Abstract][Full Text] [Related]
43. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.
Stiermaier T; Eitel I; de Waha S; Pöss J; Fuernau G; Thiele H; Desch S
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1571-1579. PubMed ID: 28439734
[TBL] [Abstract][Full Text] [Related]
44. Time-Dependent Change in Omentin-1 Level Correlated with Early Improvement of Myocardial Function in Patients with First Anterior ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.
Zhu Y; Hu C; Du Y; Zhang J; Liu J; Cheng G; Han H; Zhao Y
J Atheroscler Thromb; 2019 Oct; 26(10):856-867. PubMed ID: 30853697
[TBL] [Abstract][Full Text] [Related]
45. DL-3-n-butylphthalide Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting Mitochondrial Omi/HtrA2-Mediated Apoptosis.
Huang S; He Q; Sun X; Qu Y; Abuduxukuer R; Ren J; Zhang K; Yang Y; Guo ZN
Curr Neurovasc Res; 2023; 20(1):101-111. PubMed ID: 36852812
[TBL] [Abstract][Full Text] [Related]
46. Mitochondrial serine protease Omi/HtrA2 accentuates brain ischemia/reperfusion injury in rats and oxidative stress injury in vitro by modulating mitochondrial stress proteins CHOP and ClpP and physically interacting with mitochondrial fusion protein OPA1.
You H; Jin Y; Kang J; Mao Y; Su J; Sun L; Wang L; Meng H
Bioengineered; 2020 Dec; 11(1):1058-1070. PubMed ID: 33016225
[TBL] [Abstract][Full Text] [Related]
47. Comparison of magnetic resonance imaging findings in non-ST-segment elevation versus ST-segment elevation myocardial infarction patients undergoing early invasive intervention.
Xu J; Song YB; Hahn JY; Chang SA; Lee SC; Choe YH; Choi SH; Choi JH; Lee SH; Oh JK; Gwon HC
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1487-97. PubMed ID: 22072243
[TBL] [Abstract][Full Text] [Related]
48. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
[TBL] [Abstract][Full Text] [Related]
49. Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in rats.
Zheng J; Long M; Qin Z; Wang F; Chen Z; Li L
Pharmacol Res Perspect; 2021 Feb; 9(1):e00699. PubMed ID: 33448699
[TBL] [Abstract][Full Text] [Related]
50. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
[TBL] [Abstract][Full Text] [Related]
51. Cardiac Specific Overexpression of Mitochondrial Omi/HtrA2 Induces Myocardial Apoptosis and Cardiac Dysfunction.
Wang K; Yuan Y; Liu X; Lau WB; Zuo L; Wang X; Ma L; Jiao K; Shang J; Wang W; Ma X; Liu H
Sci Rep; 2016 Dec; 6():37927. PubMed ID: 27924873
[TBL] [Abstract][Full Text] [Related]
52. NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial.
Fabris E; Ten Berg JM; Hermanides RS; Ottervanger JP; Dambrink JHE; Gosselink AM; Sinagra G; Koopmans PC; Giannitsis E; Hamm C; van 't Hof AWJ
Am Heart J; 2021 Mar; 233():78-85. PubMed ID: 33388289
[TBL] [Abstract][Full Text] [Related]
53. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
54. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.
Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Bodí V
Int J Cardiol; 2018 Nov; 270():336-342. PubMed ID: 29954670
[TBL] [Abstract][Full Text] [Related]
55. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
[TBL] [Abstract][Full Text] [Related]
56. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
[TBL] [Abstract][Full Text] [Related]
57. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
[TBL] [Abstract][Full Text] [Related]
58. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
[TBL] [Abstract][Full Text] [Related]
59. Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Liang S; Li H; Shen X; Liu R
J Clin Lab Anal; 2019 Jun; 33(5):e22864. PubMed ID: 30779470
[TBL] [Abstract][Full Text] [Related]
60. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program.
Alexander T; Mullasari AS; Joseph G; Kannan K; Veerasekar G; Victor SM; Ayers C; Thomson VS; Subban V; Gnanaraj JP; Narula J; Kumbhani DJ; Nallamothu BK
JAMA Cardiol; 2017 May; 2(5):498-505. PubMed ID: 28273293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
